Skip to content

Dr. René Scheer, Heelkunde

Active Private limited companyfounded 2022active for 4 yearsMoorselstraat 360, 3080 TervurenKBO/BCE: BE 0790.458.740

Lifetime

4 annual accounts with figures on one time axis
peak of €277,018 in 2025
€277,018▲ 79.6%
peak of €211,116 in 2025
€211,116▲ 78.9%
peak of €169,231 in 2024
€33,146▼ 80.4%
€175,536▲ 273%
Board1 name since 2022
1 director
Documentsfilings and deeds
24-07-20267 days before the deadline
2025micro format
Gross margin from €154,258 to €277,018Result from €118,030 to €211,116Dividend €347,201Equity from €169,231 to €33,146Debts from €47,050 to €175,536Cash from €157,591 to €31,861

Key points

from the 2025 annual accounts

Equity

€33,146 from €169,231 in 2024

Equity fell by 80% in 1 year.

Turnover

≈ €560,000 estimated

The micro format states no turnover.

Debts

€175,536 84% of the balance sheet
Suppliers 0%Taxes and wages 2%Other 98%

Of this, €175,373 falls due within a year.

Liquidity

1.18 was 4.54 in 2024

Short-term debts rose from €46,978 to €175,373.

Filings

4 annual accounts since 2022
AprilJune31 JulyOctober2022202320242025

The last four annual accounts were filed 0 to 38 days before the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 7,982 companies had the same profile as Dr. René Scheer, Heelkunde has now. Each dot stands for 20 companies, two years later.

94.3%
were still trading
1.9%
stopped another way
3.7%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 7,982 companies, not a prediction for Dr. René Scheer, Heelkunde. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 05-09-2022
  • 100 sharesdeed of 07-09-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0790458740
Registered office moved from Zaventem to Tervuren The registered office moved from Tramlaan 448, 1933 Zaventem to Moorselstraat 360, 3080 Tervuren · Board meeting of 25-06-2024 · Gazette deed
Registered office moved from Boortmeerbeek to Sterrebeek The registered office moved from Heverplein 5 bus 1, 3191 Boortmeerbeek to Tramlaan 448, 1933 Sterrebeek · Board meeting of 01-05-2023 · Gazette deed
Incorporation Founding capital of €4,000, 100 shares · Founded by (oprichter comparant) · appointed as director · published on 07-09-2022 · Gazette deed
All 11 events

Official details

Source: KBO
Status
Active since 05-09-2022Normal situation
Activity
Specialist medical practiceNACE 862201 activity on the establishment unitFrom the articles, 7 activities
Establishment unit
2.335.250.4523080 Tervuren, registered on 05-09-2022
Financial year end
31 December
Peppol
Reachable since 16-12-2025
Company details

Annual accounts 2025

€208,681▼ 3.5%
Filing
Filed on 24-07-2026, 7 days before the end of the filing period
Financials

Insights on Dr. René Scheer, Heelkunde

Dr. René Scheer, Heelkunde files the micro format. That format states no turnover. The gross margin rose from €20,635 in 2022 to €277,018 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. René Scheer, Heelkunde

What is the company number of Dr. René Scheer, Heelkunde?
The company number of Dr. René Scheer, Heelkunde is 0790.458.740. The VAT number is the same number with BE in front: BE 0790.458.740.
Where is Dr. René Scheer, Heelkunde based?
The registered office is at Moorselstraat 360, 3080 Tervuren.Company details
What does Dr. René Scheer, Heelkunde do?
According to the KBO register, the main activity of the establishment unit is specialist medical practice (NACE 86220).
What is the legal form of Dr. René Scheer, Heelkunde?
Dr. René Scheer, Heelkunde is a private limited company (BV).
When was Dr. René Scheer, Heelkunde founded?
Dr. René Scheer, Heelkunde was founded on 05-09-2022.
Is Dr. René Scheer, Heelkunde still active?
Yes, Dr. René Scheer, Heelkunde is an active enterprise in the KBO register.
What is the turnover of Dr. René Scheer, Heelkunde?
The turnover in financial year 2025 is about €560,000. This figure is estimated from the gross margin of €277,018 and 1,018 comparable companies of the same size. It probably lies between €390,000 and €810,000. It is a rough estimate.Financials
Is Dr. René Scheer, Heelkunde profitable?
In financial year 2025, Dr. René Scheer, Heelkunde made a profit of €211,116.
Where can I find the annual accounts of Dr. René Scheer, Heelkunde?
Dr. René Scheer, Heelkunde filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. René Scheer, Heelkunde due?
Dr. René Scheer, Heelkunde must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.